NEW YORK (GenomeWeb) – The US Food and Drug Administration has granted Emergency Use Authorization (EUA) to Nanobiosym's Gene-Radar Zika virus test, the company said today.

According to Nanobiosym, the test is based on its Gene-Radar portable diagnostic platform and can qualitatively detect Zika RNA in human serum from individuals meeting the Centers for Disease Control and Prevention's Zika virus clinical and/or epidemiological criteria.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.